-
1
-
-
84866626878
-
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
vii27-32
-
Colombo N, Carinelli S, Colombo A, Marini C, Rollo D and Sessa C. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23 Suppl 7: vii27-32.
-
(2012)
Ann Oncol
, vol.23
-
-
Colombo, N.1
Carinelli, S.2
Colombo, A.3
Marini, C.4
Rollo, D.5
Sessa, C.6
-
2
-
-
84865972569
-
Cancer burden in Africa and opportunities for prevention
-
Jemal A, Bray F, Forman D, O'Brien M, Ferlay J, Center M and Parkin DM. Cancer burden in Africa and opportunities for prevention. Cancer 2012; 118: 4372-4384.
-
(2012)
Cancer
, vol.118
, pp. 4372-4384
-
-
Jemal, A.1
Bray, F.2
Forman, D.3
O'Brien, M.4
Ferlay, J.5
Center, M.6
Parkin, D.M.7
-
3
-
-
33745276511
-
Increased expression of pAKT is associated with radiation resistance in cervical cancer
-
Kim TJ, Lee JW, Song SY, Choi JJ, Choi CH, Kim BG, Lee JH and Bae DS. Increased expression of pAKT is associated with radiation resistance in cervical cancer. Br J Cancer 2006; 94: 1678-1682.
-
(2006)
Br J Cancer
, vol.94
, pp. 1678-1682
-
-
Kim, T.J.1
Lee, J.W.2
Song, S.Y.3
Choi, J.J.4
Choi, C.H.5
Kim, B.G.6
Lee, J.H.7
Bae, D.S.8
-
4
-
-
0032566015
-
Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2
-
Chang AC and Reddel RR. Identification of a second stanniocalcin cDNA in mouse and human: stanniocalcin 2. Mol Cell Endocrinol 1998; 141: 95-99.
-
(1998)
Mol Cell Endocrinol
, vol.141
, pp. 95-99
-
-
Chang, A.C.1
Reddel, R.R.2
-
5
-
-
0032544481
-
Molecular cloning of a second human stanniocalcin homologue (STC2)
-
Ishibashi K, Miyamoto K, Taketani Y, Morita K, Takeda E, Sasaki S and Imai M. Molecular cloning of a second human stanniocalcin homologue (STC2). Biochem Biophys Res Commun 1998; 250: 252-258.
-
(1998)
Biochem Biophys Res Commun
, vol.250
, pp. 252-258
-
-
Ishibashi, K.1
Miyamoto, K.2
Taketani, Y.3
Morita, K.4
Takeda, E.5
Sasaki, S.6
Imai, M.7
-
6
-
-
0034283394
-
Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells
-
Jellinek DA, Chang AC, Larsen MR, Wang X, Robinson PJ and Reddel RR. Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. Biochem J 2000; 350: 453-461.
-
(2000)
Biochem J
, vol.350
, pp. 453-461
-
-
Jellinek, D.A.1
Chang, A.C.2
Larsen, M.R.3
Wang, X.4
Robinson, P.J.5
Reddel, R.R.6
-
7
-
-
11144316020
-
Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs
-
Gagliardi AD, Kuo EY, Raulic S, Wagner GF and DiMattia GE. Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs. Am J Physiol Endocrinol Metab 2005; 288: E92-105.
-
(2005)
Am J Physiol Endocrinol Metab
, vol.288
, pp. E92-E105
-
-
Gagliardi, A.D.1
Kuo, E.Y.2
Raulic, S.3
Wagner, G.F.4
DiMattia, G.E.5
-
8
-
-
44949246247
-
Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro
-
Raulic S, Ramos-Valdes Y and DiMattia GE. Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro. J Endocrinol 2008; 197: 517-529.
-
(2008)
J Endocrinol
, vol.197
, pp. 517-529
-
-
Raulic, S.1
Ramos-Valdes, Y.2
DiMattia, G.E.3
-
9
-
-
78049476955
-
Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer
-
Yokobori T, Mimori K, Ishii H, Iwatsuki M, Tanaka F, Kamohara Y, Ieta K, Kita Y, Doki Y, Kuwano H and Mori M. Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer. Ann Surg Oncol 2010; 17: 2601-2607.
-
(2010)
Ann Surg Oncol
, vol.17
, pp. 2601-2607
-
-
Yokobori, T.1
Mimori, K.2
Ishii, H.3
Iwatsuki, M.4
Tanaka, F.5
Kamohara, Y.6
Ieta, K.7
Kita, Y.8
Doki, Y.9
Kuwano, H.10
Mori, M.11
-
10
-
-
70249090440
-
Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma
-
Volland S, Kugler W, Schweigerer L, Wilting J and Becker J. Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma. Int J Cancer 2009; 125: 2049-2057.
-
(2009)
Int J Cancer
, vol.125
, pp. 2049-2057
-
-
Volland, S.1
Kugler, W.2
Schweigerer, L.3
Wilting, J.4
Becker, J.5
-
11
-
-
67650074998
-
Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer
-
Ieta K, Tanaka F, Yokobori T, Kita Y, Haraguchi N, Mimori K, Kato H, Asao T, Inoue H, Kuwano H and Mori M. Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer. Int J Cancer 2009; 125: 926-931.
-
(2009)
Int J Cancer
, vol.125
, pp. 926-931
-
-
Ieta, K.1
Tanaka, F.2
Yokobori, T.3
Kita, Y.4
Haraguchi, N.5
Mimori, K.6
Kato, H.7
Asao, T.8
Inoue, H.9
Kuwano, H.10
Mori, M.11
-
12
-
-
65349172979
-
Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer
-
Tamura K, Furihata M, Chung SY, Uemura M, Yoshioka H, Iiyama T, Ashida S, Nasu Y, Fujioka T, Shuin T, Nakamura Y and Nakagawa H. Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer. Cancer Sci 2009; 100: 914-919.
-
(2009)
Cancer Sci
, vol.100
, pp. 914-919
-
-
Tamura, K.1
Furihata, M.2
Chung, S.Y.3
Uemura, M.4
Yoshioka, H.5
Iiyama, T.6
Ashida, S.7
Nasu, Y.8
Fujioka, T.9
Shuin, T.10
Nakamura, Y.11
Nakagawa, H.12
-
13
-
-
84899100112
-
Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas
-
Lin S, Guo Q, Wen J, Li C, Lin J, Cui X, Sang N and Pan J. Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas. J Exp Clin Cancer Res 2014; 33: 26.
-
(2014)
J Exp Clin Cancer Res
, vol.33
, pp. 26
-
-
Lin, S.1
Guo, Q.2
Wen, J.3
Li, C.4
Lin, J.5
Cui, X.6
Sang, N.7
Pan, J.8
-
14
-
-
84880263393
-
Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy
-
Onal C, Reyhan M, Parlak C, Guler OC and Oymak E. Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy. Int J Gynecol Cancer 2013; 23: 1104-1110.
-
(2013)
Int J Gynecol Cancer
, vol.23
, pp. 1104-1110
-
-
Onal, C.1
Reyhan, M.2
Parlak, C.3
Guler, O.C.4
Oymak, E.5
-
15
-
-
11144352119
-
Management of recurrent cervical cancer
-
Lai CH. Management of recurrent cervical cancer. Chang Gung Med J 2004; 27: 711-717.
-
(2004)
Chang Gung Med J
, vol.27
, pp. 711-717
-
-
Lai, C.H.1
-
16
-
-
84871416593
-
STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro
-
Wang H, Wu K, Sun Y, Li Y, Wu M, Qiao Q, Wei Y, Han ZG and Cai B. STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro. BMB Rep 2012; 45: 629-634.
-
(2012)
BMB Rep
, vol.45
, pp. 629-634
-
-
Wang, H.1
Wu, K.2
Sun, Y.3
Li, Y.4
Wu, M.5
Qiao, Q.6
Wei, Y.7
Han, Z.G.8
Cai, B.9
-
17
-
-
74549186565
-
Glycolytic metabolism and tumour response to fractionated irradiation
-
Sattler UG, Meyer SS, Quennet V, Hoerner C, Knoerzer H, Fabian C, Yaromina A, Zips D, Walenta S, Baumann M and Mueller-Klieser W. Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol 2010; 94: 102-109.
-
(2010)
Radiother Oncol
, vol.94
, pp. 102-109
-
-
Sattler, U.G.1
Meyer, S.S.2
Quennet, V.3
Hoerner, C.4
Knoerzer, H.5
Fabian, C.6
Yaromina, A.7
Zips, D.8
Walenta, S.9
Baumann, M.10
Mueller-Klieser, W.11
-
18
-
-
72149117661
-
Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia
-
Law AY and Wong CK. Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia. Exp Cell Res 2010; 316: 466-476.
-
(2010)
Exp Cell Res
, vol.316
, pp. 466-476
-
-
Law, A.Y.1
Wong, C.K.2
-
19
-
-
84879028316
-
Stanniocalcin-1 and -2 promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways
-
Law AY and Wong CK. Stanniocalcin-1 and -2 promote angiogenic sprouting in HUVECs via VEGF/VEGFR2 and angiopoietin signaling pathways. Mol Cell Endocrinol 2013; 374: 73-81.
-
(2013)
Mol Cell Endocrinol
, vol.374
, pp. 73-81
-
-
Law, A.Y.1
Wong, C.K.2
-
20
-
-
84892403879
-
Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer
-
Arigami T, Uenosono Y, Ishigami S, Yanagita S, Hagihara T, Haraguchi N, Matsushita D, Hirahara T, Okumura H, Uchikado Y, Nakajo A, Hokita S and Natsugoe S. Clinical significance of stanniocalcin 2 expression as a predictor of tumor progression in gastric cancer. Oncol Rep 2013; 30: 2838-2844.
-
(2013)
Oncol Rep
, vol.30
, pp. 2838-2844
-
-
Arigami, T.1
Uenosono, Y.2
Ishigami, S.3
Yanagita, S.4
Hagihara, T.5
Haraguchi, N.6
Matsushita, D.7
Hirahara, T.8
Okumura, H.9
Uchikado, Y.10
Nakajo, A.11
Hokita, S.12
Natsugoe, S.13
-
21
-
-
78149416513
-
Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells
-
Law AY and Wong CK. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells. Exp Cell Res 2010; 316: 3425-3434.
-
(2010)
Exp Cell Res
, vol.316
, pp. 3425-3434
-
-
Law, A.Y.1
Wong, C.K.2
|